Cushing’s disease – cardiovascular and metabolic complications
Cushing’s disease is excess cortisol level due to increased adrenocorticotropin secretion from pituitary adenoma. Incidence rate is 2–3 cases per year and the prevalence is 40 per 1 million people. It affects mostly young adults with high prevalence in women (incidence rate is 3–8 fold higher than i...
Main Authors: | Marta Izabela Mazur, Grzegorz Zieliński, Joanna Witek, Katarzyna Szamotulska, Przemysław Witek |
---|---|
Format: | Article |
Language: | English |
Published: |
Medical Communications Sp. z o.o.
2019-11-01
|
Series: | Pediatria i Medycyna Rodzinna |
Subjects: | |
Online Access: | http://www.pimr.pl/index.php/issues/2019-vol-15-no-3/cushing-s-disease-cardiovascular-and-metabolic-complications?aid=1380 |
Similar Items
-
Cushing syndrome in pregnancy, diagnosed after delivery
by: Han Byul Kim, et al.
Published: (2021-01-01) -
Levoketoconazole in the Treatment of Patients With Cushing’s Syndrome and Diabetes Mellitus: Results From the SONICS Phase 3 Study
by: Rosario Pivonello, et al.
Published: (2021-04-01) -
Factors predicting the outcomes of removal of corticotropinom in Cushing's disease
by: Evgenia I. Marova, et al.
Published: (2016-12-01) -
Fluconazole for Hypercortisolism in Cushing’s Disease: A Case Report and Literature Review
by: Yiming Zhao, et al.
Published: (2020-12-01) -
Lipid Abnormalities in Patients With Cushing’s Disease and Its Relationship With Impaired Glucose Metabolism
by: Xiaolin Sun, et al.
Published: (2021-02-01)